Guangzhou Baiyunshan (00874.HK, 600332.SSE) Reports Unchanged Share Capital in February 2026
Bulletin Express
Mar 03
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited released its monthly return as of 28 February 2026. The announcement states the total authorized share capital remains at 1.63 billion shares, with H shares in Hong Kong unchanged at 0.22 billion shares and A shares on the Shanghai Stock Exchange unchanged at 1.41 billion shares. Each share has a par value of RMB 1.
No movements in treasury shares or convertible instruments were reported during the period. The listed H shares continue to meet the public float requirement, indicating compliance with relevant listing rules.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.